Globus Medical (GMED) Tops Q4 EPS by 3c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.59, $0.03 better than the analyst estimate of $0.56. Revenue for the quarter came in at $274.5 million versus the consensus estimate of $276.85 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group